Globe Life Financial Statements (GL)
|
|
Report date
|
|
|
25.02.2021 |
24.02.2022 |
23.02.2023 |
31.12.2023 |
28.02.2024 |
|
06.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 738 |
5 113 |
5 215 |
5 448 |
5 448 |
|
5 728 |
Operating Income, bln rub |
|
|
895.4 |
911.2 |
996.7 |
4 720 |
1 317 |
|
3 068 |
EBITDA, bln rub |
? |
|
0.000 |
1 016 |
0.000 |
0.000 |
0.000 |
|
379.7 |
Net profit, bln rub |
? |
|
731.8 |
745.0 |
894.4 |
970.8 |
970.8 |
|
1 070 |
|
OCF, bln rub |
? |
|
1 476 |
1 438 |
1 422 |
0.000 |
1 482 |
|
1 066 |
CAPEX, bln rub |
? |
|
41.8 |
38.2 |
27.9 |
0.000 |
49.6 |
|
56.0 |
FCF, bln rub |
? |
|
1 435 |
1 399 |
1 394 |
0.000 |
1 433 |
|
1 009 |
Dividend payout, bln rub
|
|
|
78.2 |
80.0 |
80.5 |
0.000 |
84.1 |
|
65.3 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
10.7% |
10.7% |
9.01% |
0.00% |
8.67% |
|
6.10% |
|
OPEX, bln rub |
|
|
3 843 |
4 202 |
3 864 |
727.5 |
5 448 |
|
1 670 |
Cost of production, bln rub |
|
|
301.0 |
322.0 |
354.0 |
0.000 |
347.8 |
|
297.2 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
86.7 |
83.5 |
90.4 |
102.3 |
102.3 |
|
91.4 |
|
Assets, bln rub |
|
|
29 047 |
29 768 |
25 537 |
0.000 |
28 051 |
|
29 557 |
Net Assets, bln rub |
? |
|
8 771 |
8 643 |
4 896 |
0.000 |
4 487 |
|
4 639 |
Debt, bln rub |
|
|
1 923 |
2 026 |
2 077 |
0.000 |
2 116 |
|
2 761 |
Cash, bln rub |
|
|
21 416 |
21 467 |
16 710 |
0.000 |
103.2 |
|
235.1 |
Net debt, bln rub |
|
|
-19 493 |
-19 440 |
-14 633 |
0.00 |
2 013 |
|
2 526 |
|
Ordinary share price, rub |
|
|
95.0 |
93.7 |
120.6 |
121.7 |
121.7 |
|
115.9 |
Number of ordinary shares, mln |
|
|
106.1 |
102.1 |
97.9 |
96.4 |
95.1 |
|
87.9 |
|
Market cap, bln rub |
|
|
10 073 |
9 566 |
11 805 |
11 729 |
11 575 |
|
10 180 |
EV, bln rub |
? |
|
-9 420 |
-9 874 |
-2 828 |
11 729 |
13 588 |
|
12 706 |
Book value, bln rub |
|
|
7 888 |
7 679 |
3 932 |
0 |
4 005 |
|
4 148 |
|
EPS, rub |
? |
|
6.90 |
7.30 |
9.13 |
10.1 |
10.2 |
|
12.2 |
FCF/share, rub |
|
|
13.5 |
13.7 |
14.2 |
0.00 |
15.1 |
|
11.5 |
BV/share, rub |
|
|
74.4 |
75.2 |
40.2 |
0.00 |
42.1 |
|
47.2 |
|
EBITDA margin, % |
? |
|
0.00% |
19.9% |
0.00% |
0.00% |
0.00% |
|
6.63% |
Net margin, % |
? |
|
15.4% |
14.6% |
17.2% |
17.8% |
17.8% |
|
18.7% |
FCF yield, % |
? |
|
14.2% |
14.6% |
11.8% |
0.00% |
12.4% |
|
9.92% |
ROE, % |
? |
|
8.34% |
8.62% |
18.3% |
|
21.6% |
|
23.1% |
ROA, % |
? |
|
2.52% |
2.50% |
3.50% |
|
3.46% |
|
3.62% |
|
P/E |
? |
|
13.8 |
12.8 |
13.2 |
12.1 |
11.9 |
|
9.52 |
P/FCF |
|
|
7.02 |
6.84 |
8.47 |
|
8.08 |
|
10.1 |
P/S |
? |
|
2.13 |
1.87 |
2.26 |
2.15 |
2.12 |
|
1.78 |
P/BV |
? |
|
1.28 |
1.25 |
3.00 |
|
2.89 |
|
2.45 |
EV/EBITDA |
? |
|
|
-9.72 |
|
|
|
|
33.5 |
Debt/EBITDA |
|
|
|
-19.1 |
|
|
|
|
6.65 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
|
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
0.88% |
0.75% |
0.54% |
0.00% |
0.91% |
|
0.98% |
|
Globe Life shareholders |